Word

CELLECTIS

Status

Registered

Status Code

800

Status Date

Thursday, February 12, 2015

Serial Number

76210655

Registration Number

2872075

Registration Date

Tuesday, August 10, 2004

Mark Type

1000

Filing Date

Tuesday, February 13, 2001

Published for Opposition

Tuesday, February 18, 2003

Trademark Owner History

Cellectis S.A. - Original Registrant

Classifications

9 Scientific devices and instruments enabling implementation of biochemical analysis techniques and molecular biology techniques, namely automated biochemical analyser, automated protein production and protein purification devices, biochemical, biological automated assay devices, nucleic acid break analyser, analyzer for automatically measuring and researching interactions of biomolecules, device for protein-nucleic acid interaction analysis; apparatus for use in analysis and array-tests, qualitative and quantitative detection of analytes in samples, namely, DNA sequencing, receptor-ligand interaction, protein analysis, mass-spectrometry, nucleic acid hybridization and detection, thermo-cycler systems, microarray-printer, microarray-reader; scientific devices and instruments enabling the mapping of the biological activities of all molecules; information processing equipment, namely, computer software for molecular design, sequence analysis, sequence generation, design and analysis for molecules, namely polypeptides or polynucleotides used in genetic engineering, design and analysis of meganucleases and endonucleases and for design and analysis of genetic recombination systems, hardware and component parts, namely, processors, memory banks, peripheral controllers; multimedia products, namely, prerecorded magnetic tapes, CD-ROMs, containing image and sound recordings in the fields of chemistry, biology, biochemistry, molecular biology, bacteriology; software programs namely, software for providing an on-line computer database in the field of pharmaceuticals and biotechnology; software for searching, retrieving, storing, maintaining and managing data in the field of pharmaceuticals and biotechnology; software for use in the field of scientific information management; software for use in drug discovery; software for biomolecules analysis, nucleic acids and proteins sequences evaluation, chemical, medical and biological data bank searches and analysis, physiological data analysis, genetic data analysis, chemical formulae analysis, structural prediction for biological and chemical molecules; software for writing biological molecule sequence; molecular design software for analysis, simulation and design of biological, chemical, and material systems; software for molecular design in the biotechnology and pharmaceutical field; software for use in biological and chemical modeling, analysis and information management; software for integrated global management

5 Pharmaceutical, veterinary and health-care products, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination system, cells engineered by meganulease recombination system for use in genetic or viral diseases; microorganism cultures and preparation for medical, pharmaceutical and veterinary use, namely microoganisms engineered by meganuclease recombination system for use in genetic or viral diseases, cancers and vaccines; microorganisms producing polypeptides for in vivo and vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination system for use in genetic or viral diseases; bacteriological preparations for medical, pharmaceutical and veterinary use namely bacteriological preparations engineered by meganuclease recombination system; bacteriological preparations producing polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination system; drugs for veterinary use, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic and acid vectors, molecular scissors for use in genetic or viral diseases; biological preparation for medical, pharmaceutical and veterinary use namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleaes, nucleic and vectors, molecular scissors, ready to use genomic recombination system, cells engineered by meganuclease recombination system for use in genetic or viral diseases; chemopharmaceutical preparations; diagnostic preparations for clinical or medical laboratory use

1 Chemical, biochemical, biotechnological products intended for industry, agriculture, horticulture, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; ready to use genomic recombination system, namely, meganuclease recombination agents for use in genetic engineering of cells and animals, namely rodent and fish , for scientific, laboratory or medical research; chemical, biochemical, biotechnological and bacteriological products intended for research laboratories and control laboratories, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination agents for use in connection with cells and animals for scientific, laboratory or medical research; chemical, biochemical, biotechnological products and bacteriological preparations for sciences, namely polypeptides for in vivo and in vitro genetic engineering; natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination agents for use in connection with cells and animals for scientific, laboratory or medical research; diagnostic preparation, namely natural and engineered meganucleases and endonucleases, molecular scissors for scientific or research use; proteins as raw materials; microorganisms used for producing therapeutical compounds or vaccines; chemical and biochemical preparations for medical, pharmaceutical and veterinary use, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination agents for scientific or research use

42 Scientific and industrial research; research in genetic, medical, pharmaceutical and veterinary fields; research in chemistry, biology, biochemistry, molecular biology, bacteriology; scientific analysis; research and development for others of techniques of biochemical analysis, biological analysis, molecular biology techniques; research and development for others of new molecules intended for industry; laboratory research in the fields of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology, agriculture; medical services; studies of technical projects in the field of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology, agriculture; testing, analysis and evaluation of engineering works for others; licensing of patents and intellectual property; computer programming for others, development for others of multimedia software programs

Trademark Events

Oct 18, 2023

Teas Change Of Correspondence Received

Oct 18, 2023

Teas Change Of Domestic Representatives Address

Oct 18, 2023

Teas Withdrawal As Domestic Representative Received

Oct 18, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Oct 18, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Oct 18, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Oct 18, 2023

Teas Change Of Owner Address Received

Aug 10, 2023

Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed

Feb 12, 2015

Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed

Feb 12, 2015

Registered And Renewed (First Renewal - 10 Yrs)

Feb 12, 2015

Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted

Feb 10, 2015

Teas Section 8 & 9 Received

Feb 10, 2015

Applicant/Correspondence Changes (Non-Responsive) Entered

Feb 10, 2015

Teas Change Of Owner Address Received

Aug 27, 2010

Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.

Aug 6, 2010

Registered - Sec. 8 (6-Yr) & Sec. 15 Filed

Aug 27, 2010

Case Assigned To Post Registration Paralegal

Aug 6, 2010

Teas Section 8 & 15 Received

Aug 10, 2004

Registered-Principal Register

Jun 1, 2004

Allowed Principal Register - Sou Accepted

May 26, 2004

Assigned To Examiner

May 26, 2004

Statement Of Use Processing Complete

May 11, 2004

Use Amendment Filed

May 21, 2004

Case File In Ticrs

May 11, 2004

Fax Received

May 11, 2004

Paper Received

Dec 9, 2003

Sou Extension 1 Granted

Nov 13, 2003

Sou Extension 1 Filed

Nov 13, 2003

Paper Received

May 13, 2003

Noa Mailed - Sou Required From Applicant

Feb 18, 2003

Published For Opposition

Jan 29, 2003

Notice Of Publication

Dec 16, 2002

Approved For Pub - Principal Register

Nov 22, 2002

Examiners Amendment Mailed

Nov 21, 2002

Previous Allowance Count Withdrawn

Nov 21, 2002

Approved For Pub - Principal Register

Sep 30, 2002

Correspondence Received In Law Office

Sep 30, 2002

Paper Received

May 20, 2002

Final Refusal Mailed

Nov 19, 2001

Correspondence Received In Law Office

Nov 21, 2001

Correspondence Received In Law Office

Jun 15, 2001

Non-Final Action Mailed

Jun 12, 2001

Assigned To Examiner